ArticleEuropean journal of pediatrics2026
Long-term effects of hematopoietic stem cell transplantation on endocrine function in childhood and adolescence: a single tertiary care center study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study is to evaluate long-term endocrine dysfunctions in pediatric hematopoietic stem cell transplantation (HSCT) survivors. This retrospective study analyzed 141 pediatric HSCT recipients (75 males, 66 females). Endocrine outcomes, including gonadal dysfunction, hypothyroidism, growth hormone deficiency, and adrenal insufficiency, were assessed through clinical evaluations and laboratory tests. Statistical analyses examined associations between conditioning regimens and endocrine complications. Endocrine dysfunction was diagnosed in 46.1% of patients, with a higher prevalence in females (72.7% vs. 22.7% in males). The most striking finding was gonadal dysfunction, which occurred exclusively in girls, and occurred in 72% of female patients, all of whom received myeloablative conditioning. Hypothyroidism was seen in approximately 20% of patients, while growth hormone deficiency and adrenal insufficiency occurred in 3% and 9% of patients respectively.
conclusionThe study highlights the gender-specific vulnerabilities in endocrine outcomes following HSCT, emphasizes the critical importance of long-term endocrine surveillance and early interventions to mitigate the burden of these complications, and stresses the necessity of optimizing guidelines for endocrine care in this vulnerable population, ultimately enhancing quality of life and long-term outcomes for HSCT survivors. WHAT IS KNOWN: • Hematopoietic stem cell transplantation (HSCT) is an important curative therapy for several debilitating and life-threatening conditions, but this is associated with many endocrine dysfunctions. • There is currently a lack of standardized screening guidelines based on timing, age, and gender for detecting endocrine disorders in children who survived HSCT. WHAT IS NEW: • Endocrine dysfunction was diagnosed in 46.1% of patients, with a higher prevalence in females (72.7% vs. 22.7% in males); the gonadal dysfunction with no pubertal onset and absent secondary sexual characteristics occurred exclusively in girls. • Reduced intensity conditioning regimens can reduce the endocrine dysfunction, while standard screening protocols can improve early diagnosis and management.
Indexed as
Identifiers
42252329What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.